In vitro activity of cefiderocol in Pseudomonas aeruginosa isolates from people with cystic fibrosis recovered during three multicentre studies in Spain.

Ainhize Maruri-AransoloCarla López-CausapéMarta Hernandez-GarcíaMaría García-CastilloJuan de Dios Caballero-PérezAntonio OliverRafael Cantón

Published in: The Journal of antimicrobial chemotherapy (2024)

Our results position cefiderocol as a therapeutic option in pwCF infected with P. aeruginosa resistant to most recent β-lactam/β-lactamase inhibitor combinations.

Keyphrases

gram negative
pseudomonas aeruginosa
multidrug resistant
acinetobacter baumannii
cystic fibrosis
clinical trial
drug resistant
biofilm formation
study protocol
case control
klebsiella pneumoniae
cross sectional
double blind
escherichia coli
randomized controlled trial
staphylococcus aureus